The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies

C P Engelfriet; H W Reesink; P M Mannucci; A Gringeri; J Ingerslev; D B Brettler; E P Mauser-Bunschoten; C Negrier; Erik Berntorp; O P Smith; A D Shapiro

doi:10.1046/j.1423-0410.2000.78402561.x

The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies

C P Engelfriet, H W Reesink, P M Mannucci, A Gringeri, J Ingerslev, D B Brettler, E P Mauser-Bunschoten, C Negrier, Erik Berntorp, O P Smith, A D Shapiro

Clinical Coagulation, Malmö

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	256-257
Journal	Vox Sanguinis
Volume	78
Issue number	4
DOIs	https://doi.org/10.1046/j.1423-0410.2000.78402561.x
Publication status	Published - 2000

Subject classification (UKÄ)

Hematology

Access to Document

10.1046/j.1423-0410.2000.78402561.x

Cite this

@article{4fb0611956d746c3bf02521344adc410,

title = "The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies",

author = "Engelfriet, \{C P\} and Reesink, \{H W\} and Mannucci, \{P M\} and A Gringeri and J Ingerslev and Brettler, \{D B\} and Mauser-Bunschoten, \{E P\} and C Negrier and Erik Berntorp and Smith, \{O P\} and Shapiro, \{A D\}",

year = "2000",

doi = "10.1046/j.1423-0410.2000.78402561.x",

language = "English",

volume = "78",

pages = "256--257",

journal = "Vox Sanguinis",

issn = "1423-0410",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies

AU - Engelfriet, C P

AU - Reesink, H W

AU - Mannucci, P M

AU - Gringeri, A

AU - Ingerslev, J

AU - Brettler, D B

AU - Mauser-Bunschoten, E P

AU - Negrier, C

AU - Berntorp, Erik

AU - Smith, O P

AU - Shapiro, A D

PY - 2000

Y1 - 2000

UR - https://www.scopus.com/pages/publications/0033940503

U2 - 10.1046/j.1423-0410.2000.78402561.x

DO - 10.1046/j.1423-0410.2000.78402561.x

M3 - Article

SN - 1423-0410

VL - 78

SP - 256

EP - 257

JO - Vox Sanguinis

JF - Vox Sanguinis

IS - 4

ER -

The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies

Subject classification (UKÄ)

Access to Document

Other files and links

Cite this